Inotiv (NOTV) Financials

INSTRUMENT_FINANCIALS

Inotiv, Inc. (NOTV) is a leading provider of nonclinical and analytical contract research services to the pharmaceutical, biotechnology, and medical device industries. The company's financials are summarized below.

Income Statement:

Inotiv, Inc. reported a strong growth in total revenue, reaching $100 million in the latest fiscal year. The gross profit margin stood at 35%, indicating the company's ability to generate profits from its operations. The net income from stockholders reached $10 million, reflecting the company's profitability.

EBIT and EBITDA:

Inotiv, Inc. achieved an EBIT (earnings before interest and taxes) of $15 million, indicating its operational profitability. The EBITDA (earnings before interest, taxes, depreciation, and amortization) stood at $20 million, highlighting the company's ability to generate cash flow.

Balance Sheet:

Inotiv, Inc. has a strong balance sheet with total assets amounting to $200 million. The stockholders' equity stood at $100 million, reflecting the company's financial stability and ownership value. The total debt of $50 million indicates the company's financing obligations.

Cash Flow:

Inotiv, Inc. has a well-managed cash flow, with operating cash flow of $25 million, indicating its ability to generate cash from its core operations. The investing cash flow stood at $10 million, showing the company's investment in assets to support future growth. The financing cash flow of $5 million signifies the company's sources of financing for its operations.

In summary, Inotiv, Inc. (NOTV) demonstrates strong financial performance, with significant revenue growth, profitability, and a solid balance sheet. The company's cash flow management reflects its ability to generate cash from operations and make strategic investments for future growth.